Literature DB >> 16153529

Hydroxychloroquine-induced cardiotoxicity in a 39-year-old woman with systemic lupus erythematosus and systolic dysfunction.

Richard J Keating1, Sundeep Bhatia, Shreyasee Amin, Amy Williams, Lawrence J Sinak, William D Edwards.   

Abstract

A 39-year-old woman with a history of systemic lupus erythematosus developed chest pain and conduction abnormalities. An echocardiographic examination revealed systolic dysfunction and ventricular thickening. Because of the unclear nature of her cardiac disease, right ventricular endomyocardial biopsy was performed. Light microscopy showed diffuse myocyte vacuolization without myocarditis, and transmission electron microscopy demonstrated sarcoplasmic myelinoid and curvilinear bodies, diagnostic of hydroxychloroquine toxicity. Among patients with autoimmune connective disorders, cardiac dysfunction may be a result of the disease or occasionally of its treatment. Although the nature of the cardiac disease (myocardial, valvular, or pericardial) can generally be evaluated echocardiographically, endomyocardial biopsy may be indicated to rule out diseases with a specific microscopic appearance, such as myocarditis or hydroxychloroquine cardiotoxicity.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16153529     DOI: 10.1016/j.echo.2005.01.012

Source DB:  PubMed          Journal:  J Am Soc Echocardiogr        ISSN: 0894-7317            Impact factor:   5.251


  12 in total

1.  Cardiac Complications Attributed to Chloroquine and Hydroxychloroquine: A Systematic Review of the Literature.

Authors:  Clotilde Chatre; François Roubille; Hélène Vernhet; Christian Jorgensen; Yves-Marie Pers
Journal:  Drug Saf       Date:  2018-10       Impact factor: 5.606

2.  Cardiotoxicity after low-dose chloroquine antimalarial therapy.

Authors:  Gabriele Fragasso; Francesca Sanvito; Francesca Baratto; Sabina Martinenghi; Claudio Doglioni; Alberto Margonato
Journal:  Heart Vessels       Date:  2009-09-27       Impact factor: 2.037

3.  Hydroxychloroquine cardiotoxicity presenting as a rapidly evolving biventricular cardiomyopathy: key diagnostic features and literature review.

Authors:  Emer Joyce; Aurelie Fabre; Niall Mahon
Journal:  Eur Heart J Acute Cardiovasc Care       Date:  2013-03

4.  A case of chloroquine-induced cardiomyopathy that presented as sick sinus syndrome.

Authors:  Jae Hak Lee; Woo-Baek Chung; Ju Hyun Kang; Hyung Woo Kim; Jin Jin Kim; Ji Hyun Kim; Hui-Jeong Hwang; Jea Beom Lee; Jong Won Chung; Hyo Lim Kim; Yun Seok Choi; Chul Soo Park; Ho-Joong Youn; Man Young Lee
Journal:  Korean Circ J       Date:  2010-11-30       Impact factor: 3.243

Review 5.  Current and Future Use of Chloroquine and Hydroxychloroquine in Infectious, Immune, Neoplastic, and Neurological Diseases: A Mini-Review.

Authors:  Domenico Plantone; Tatiana Koudriavtseva
Journal:  Clin Drug Investig       Date:  2018-08       Impact factor: 3.580

6.  Hydroxychloroquine reduces heart rate by modulating the hyperpolarization-activated current If: Novel electrophysiological insights and therapeutic potential.

Authors:  Rebecca A Capel; Neil Herring; Manish Kalla; Arash Yavari; Gary R Mirams; Gillian Douglas; Gil Bub; Keith Channon; David J Paterson; Derek A Terrar; Rebecca-Ann B Burton
Journal:  Heart Rhythm       Date:  2015-05-27       Impact factor: 6.343

Review 7.  Cardiac effects and toxicity of chloroquine: a short update.

Authors:  Kanigula Mubagwa
Journal:  Int J Antimicrob Agents       Date:  2020-06-19       Impact factor: 5.283

Review 8.  Hydroxychloroquine: from malaria to autoimmunity.

Authors:  Ilan Ben-Zvi; Shaye Kivity; Pnina Langevitz; Yehuda Shoenfeld
Journal:  Clin Rev Allergy Immunol       Date:  2012-04       Impact factor: 8.667

9.  Cardiac Toxicity of Chloroquine or Hydroxychloroquine in Patients With COVID-19: A Systematic Review and Meta-regression Analysis.

Authors:  Imad M Tleyjeh; Zakariya Kashour; Oweida AlDosary; Muhammad Riaz; Haytham Tlayjeh; Musa A Garbati; Rana Tleyjeh; Mouaz H Al-Mallah; M Rizwan Sohail; Dana Gerberi; Aref A Bin Abdulhak; John R Giudicessi; Michael J Ackerman; Tarek Kashour
Journal:  Mayo Clin Proc Innov Qual Outcomes       Date:  2020-11-02

10.  Heart failure in a woman with SLE, anti-phospholipid syndrome and Fabry's disease.

Authors:  A Nandagudi; E C Jury; D Alonzi; T D Butters; S Hughes; D A Isenberg
Journal:  Lupus       Date:  2013-07-17       Impact factor: 2.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.